Invesaro

Stocks Health care PSNL

NASDAQ · Health care

Personalis, Inc. (PSNL)

Personalis, Inc. brought in $69.7M of revenue over the twelve months to June 30, 2026, down 13.3% from a year earlier. It posted a net loss of $107.2M. In fiscal 2025 capital spending exceeded operating cash flow by $79.5M. At June 30, 2026 it held $94M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.

Price
$16.46
-0.66% on the day · September 25, 2026
52-week range $4.96 to $18.89
Market cap
$1.8B
Revenue (last 12 months)
$69.7M
-13.3% year on year
Net margin
-153.8%

What Personalis, Inc. does

Personalis, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker PSNL.

Revenue and profit by year

Revenue
FY19: $37.8M $37.8M FY19FY19: $65.2M $65.2M FY19FY20: $78.6M $78.6M FY20FY21: $85.5M $85.5M FY21FY22: $65M $65M FY22FY23: $73.5M $73.5M FY23FY24: $84.6M $84.6M FY24FY25: $69.6M $69.6M FY25
Net income
FY19: -$19.9M -$19.9M FY19FY19: -$25.1M -$25.1M FY19FY20: -$41.3M -$41.3M FY20FY21: -$65.2M -$65.2M FY21FY22: -$113.3M -$113.3M FY22FY23: -$108.3M -$108.3M FY23FY24: -$81.3M -$81.3M FY24FY25: -$81.3M -$81.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$69.6M-$88.1M-$81.3M-$0.91-$79.5M
2024$84.6M-$68.3M-$81.3M-$1.37-$46.8M
2023$73.5M-$109.9M-$108.3M-$2.25-$67.2M
2022$65M-$115.5M-$113.3M-$2.48-$120.1M
2021$85.5M-$65.4M-$65.2M-$1.49-$81.9M
2020$78.6M-$42.1M-$41.3M-$1.20-$45.9M

Latest SEC filings

What Personalis, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 31, 2026
  2. August 20, 2026
  3. August 14, 2026
  4. August 4, 2026
    Quarterly report 10-Q · period to June 30, 2026
  5. August 4, 2026
  6. July 29, 2026
  7. July 20, 2026
  8. July 20, 2026
  9. July 20, 2026
  10. July 20, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 22, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about PSNL

What does Personalis, Inc. do?

Personalis, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker PSNL.

Is Personalis, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $107.2M on revenue of $69.7M.

How much revenue does Personalis, Inc. make?

Over the twelve months to June 30, 2026 Personalis, Inc. reported revenue of $69.7M. That is 13.3% less than a year earlier.

When did Personalis, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 22, 2026.

Similar companies

Follow PSNL

Get an email when Personalis, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PSNL: get an email when it files

Where the numbers come from

Financial figures are the values Personalis, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.